D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
GE Vernova
GEV
|
+$601M |
| 2 |
Walt Disney
DIS
|
+$510M |
| 3 |
Palantir
PLTR
|
+$502M |
| 4 |
Financial Select Sector SPDR Fund
XLF
|
+$490M |
| 5 |
TSMC
TSM
|
+$396M |
Top Sells
| 1 |
Boeing
BA
|
+$967M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$951M |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
+$567M |
| 4 |
Eli Lilly
LLY
|
+$551M |
| 5 |
Arthur J. Gallagher & Co
AJG
|
+$499M |
Sector Composition
| 1 | Technology | 20.32% |
| 2 | Healthcare | 13% |
| 3 | Consumer Discretionary | 12.32% |
| 4 | Financials | 8.62% |
| 5 | Industrials | 7.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1051
Fulgent Genetics
FLGT
$667M
| $7.44M | 0.01% |
440,016
+309,332
| +237% | +$5.23M |
|
1052
Aaon
AAON
$6.93B
| $7.42M | 0.01% |
94,955
+86,603
| +1,037% | +$6.77M |
|
1053
Nucor
NUE
$32.6B
| $7.4M | 0.01% |
61,500
-296,532
| -83% | -$35.7M |
|
1054
KB Financial Group
KB
$30.8B
| $7.38M | 0.01% |
136,474
+117,525
| +620% | +$6.36M |
|
1055
Celldex Therapeutics
CLDX
$1.67B
| $7.37M | 0.01% |
406,161
-112,179
| -22% | -$2.04M |
|
1056
Rapid7
RPD
$1.26B
| $7.37M | 0.01% |
277,999
+13,995
| +5% | +$371K |
|
|
SGI
1057
Somnigroup International Inc.
SGI
$17.9B
| $7.37M | 0.01% |
123,072
-224,901
| -65% | -$13.5M |
|
1058
Community Health Systems
CYH
$409M
| $7.34M | 0.01% |
2,720,295
-151,860
| -5% | -$410K |
|
1059
Alkami Technology
ALKT
$2.62B
| $7.34M | 0.01% |
279,535
+51,831
| +23% | +$1.36M |
|
1060
Owens & Minor
OMI
$423M
| $7.33M | 0.01% |
812,233
+148,515
| +22% | +$1.34M |
|
1061
Element Solutions
ESI
$6.24B
| $7.33M | 0.01% |
324,230
-6,757
| -2% | -$153K |
|
|
NVRO
1062
DELISTED
NEVRO CORP.
NVRO
| $7.31M | 0.01% |
1,251,830
-551,702
| -31% | -$3.22M |
|
1063
SK Telecom
SKM
$8.33B
| $7.31M | 0.01% |
343,630
+169,633
| +97% | +$3.61M |
|
1064
Labcorp
LH
$22.7B
| $7.3M | 0.01% |
31,376
-24,392
| -44% | -$5.68M |
|
1065
A.O. Smith
AOS
$10.2B
| $7.3M | 0.01% |
111,694
-280,769
| -72% | -$18.4M |
|
|
TBI
1066
Trueblue
TBI
$171M
| $7.28M | 0.01% |
1,371,135
-53,677
| -4% | -$285K |
|
|
SHYF
1067
DELISTED
The Shyft Group
SHYF
| $7.26M | 0.01% |
897,517
-51,999
| -5% | -$421K |
|
1068
Evergy
EVRG
$16.5B
| $7.25M | 0.01% |
105,099
+23,344
| +29% | +$1.61M |
|
1069
Omega Healthcare
OHI
$12.6B
| $7.24M | 0.01% |
190,078
-319,047
| -63% | -$12.1M |
|
1070
ESCO Technologies
ESE
$5.3B
| $7.23M | 0.01% |
45,446
+24,631
| +118% | +$3.92M |
|
|
NML
1071
Neuberger Berman Energy Infrastructure and Income Fund
NML
$490M
| $7.22M | 0.01% |
802,641
| – | – |
|
1072
Mativ Holdings
MATV
$666M
| $7.21M | 0.01% |
1,157,965
+653,543
| +130% | +$4.07M |
|
1073
Urban Edge Properties
UE
$2.67B
| $7.21M | 0.01% |
379,637
+279,542
| +279% | +$5.31M |
|
1074
Old Republic International
ORI
$9.92B
| $7.15M | 0.01% |
182,320
+173,888
| +2,062% | +$6.82M |
|
1075
Rumble
RUM
$2.48B
| $7.14M | 0.01% |
1,009,374
-342,429
| -25% | -$2.42M |
|